Doses, serum concentrations and diagnoses of Norwegian quetiapine users 2001–2019 in a therapeutic drug monitoring material

Håvard Breivik,Andreas Austgulen Westin,Joachim Frost
DOI: https://doi.org/10.1111/bcpt.14074
2024-09-03
Basic & Clinical Pharmacology & Toxicology
Abstract:Over the past decade, increasing off‐label use of quetiapine has been reported worldwide from various sources. We wanted to investigate how this is reflected in therapeutic drug monitoring (TDM) data. Requisitions for serum concentration measurements of quetiapine from a TDM service in Central Norway during 2001–2019 were obtained and analysed for age, gender, trends in quetiapine doses, serum concentrations and indicators of diagnoses. There were 19 759 requisitions from 7459 individuals. Daily doses of quetiapine decreased by 24 mg per year (95% CI: −25.61 to −21.48, p
pharmacology & pharmacy,toxicology
What problem does this paper attempt to address?